Old Mission Capital’s ResMed RMD Stock Holding History

Old Mission Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,226	Closed	-$2.53M	–	1697
2024 Q2	$2.53M	Buy	13,226 +3,326	+34%	+$675K	0.04%	267
2024 Q1	$1.96M	Sell	9,900 -18,573	-65%	-$3.4M	0.03%	328
2023 Q4	$4.9M	Sell	28,473 -57,730	-67%	-$8.87M	0.09%	191
2023 Q3	$12.7M	Buy	86,203 +27,604	+47%	+$4.99M	0.28%	74
2023 Q2	$12.8M	Buy	+58,599	New	+$13.1M	0.28%	70
2022 Q3	–	Sell	-110,158	Closed	-$23.1M	–	1286
2022 Q2	$23.1M	Buy	+110,158	New	+$23.5M	0.65%	24
2021 Q3	–	Sell	-114,483	Closed	-$28.2M	–	1224
2021 Q2	$28.2M	Buy	114,483 +42,321	+59%	+$8.9M	0.96%	12
2021 Q1	$14M	Buy	+72,162	New	+$14.5M	0.78%	20
2017 Q1	–	Sell	-3,523	Closed	-$219K	–	435
2016 Q4	$219K	Sell	3,523 -17,785	-83%	-$1.09M	0.02%	348
2016 Q3	$1.38M	Buy	+21,308	New	+$1.42M	0.09%	139

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Old Mission Capital's RMD Position: Q3 2024 in Review

Old Mission Capital sold out of ResMed (RMD) in Q3 2024, closing a stake of 13,226 shares — an estimated $2.53M sold.

Old Mission Capital first reported a position in RMD in Q3 2016 and held it in 10 quarters. The position peaked at $28.2M in Q2 2021. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

Old Mission Capital reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
Old Mission Capital sold 13,226 ResMed shares in Q3 2024, an estimated $2.53M.
Old Mission Capital first reported a position in ResMed in Q3 2016 and held it in 10 quarters.
Old Mission Capital's ResMed position peaked at $28.2M in Q2 2021.
801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Old Mission Capital's 13F filing for Q3 2024, filed 14 Nov 2024.